Black Diamond Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Black Diamond Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2020 to Q3 2024.
  • Black Diamond Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -49.7 %, a 13.8% increase year-over-year.
  • Black Diamond Therapeutics, Inc. annual Return On Assets for 2023 was -56.2 %, a 16.4% decline from 2022.
  • Black Diamond Therapeutics, Inc. annual Return On Assets for 2022 was -48.3 %, a 7.96% decline from 2021.
  • Black Diamond Therapeutics, Inc. annual Return On Assets for 2021 was -44.7 %, a 131% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -49.7 +7.96 +13.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 -51.7 +4.23 +7.57% Apr 1, 2024 Jun 30, 2024
Q1 2024 -53.8 -2.21 -4.29% Jan 1, 2024 Mar 31, 2024
Q4 2023 -56.2 -7.93 -16.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -57.6 -12.3 -27% Jul 1, 2023 Sep 30, 2023
Q2 2023 -55.9 -9.37 -20.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -51.6 -4.63 -9.86% Jan 1, 2023 Mar 31, 2023
Q4 2022 -48.3 -3.56 -7.96% Oct 1, 2022 Dec 31, 2022
Q3 2022 -45.4 -4.73 -11.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -46.5 -13.6 -41.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -47 -21.4 -84% Jan 1, 2022 Mar 31, 2022
Q4 2021 -44.7 -25.4 -131% Oct 1, 2021 Dec 31, 2021
Q3 2021 -40.6 -22.7 -127% Jul 1, 2021 Sep 30, 2021
Q2 2021 -32.9 Apr 1, 2021 Jun 30, 2021
Q1 2021 -25.5 Jan 1, 2021 Mar 31, 2021
Q4 2020 -19.4 Oct 1, 2020 Dec 31, 2020
Q3 2020 -17.9 Jul 1, 2020 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.